Experimental oncology

The experimental oncology group is engaged in research in the following areas:
- new controlled materials for drug delivery to the tumor
- molecular mechanisms of the death of tumor cells upon separation of the interaction of p53 and Mdm2
- targeted inhibition of Clk protein kinase to induce the death of tumor cells
- necroptosis in antitumor therapy